Articles

The two new injectable drugs, alirocumab and evolocumub, have been recommended for FDA approval by the agency’s Endocrinologic and Metabolic Advisory Committee.…

Fixed-dose insulin glargine/lixisenatide improves HbA1c levels in patients with type 2 diabetes…

GLP-1 analog also showed reduction in weight and incidence of hypoglycemia… Dulaglutide (Trulicity) is a glucagon-like peptide analog that is used once weekly to improve blood glucose level. During the open-label, multinational, parallel arm study, researchers compared the safety and efficacy of dulaglutide 0.75mg and 1.5mg to insulin glargine in …

C-peptide and islet autoantibodies may serve as biomarkers to predict the risk of severe hypo’s during intensification of type 2 diabetes treatment….

Those women who continued to exercise throughout their pregnancy achieved an even higher risk reduction… Gestational diabetes and excessive maternal weight gain are associated with many negative outcomes for both the mother and the baby including: pre-eclampsia, hypertension and preterm birth. Expectant mothers who are diagnosed with gestational diabetes are …

Early detection and treatment of type 2 diabetes may be more beneficial than aggressive control of blood glucose, blood pressure and cholesterol… Screening to identify type 2 diabetes followed by early treatment could result in substantial health benefits, according to new research that combined large scale clinical observations and innovative …

Toxin produced by Staphylococcus aureus (S. aureus), a common skin bacteria, caused glucose intolerance in rabbit cells… Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers …

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, is a promising option as adjunct therapy for type 1 diabetes patients… In a randomized double blind phase 2 study, 33 type 1 diabetic patients were treated with either sotagliflozin or placebo. Researchers assessed safety, glycemic control, bolus insulin dose reduction which was …

American Diabetes Association (ADA), American Association of Diabetes Educators (AADE) and the Academy of Nutrition and Dietetics (AND) joint position statement…. There are four times the need for diabetes self-management education and support should be assessed: at diagnosis, annually, when there are new complications and during transitions of care. Research …

How low should we go? A new study is a 10-year follow-up to the Veterans Affairs Diabetes Trial in which 1,791 type 2 diabetics over the age of 60 were enrolled. The veterans were randomly placed in either the “standard” therapy group that had a higher HbA1c goal or the …